Five Antiretroviral Drug Class-Resistant HIV-1 in a Treatment-Naïve Patient Successfully Suppressed with Optimized Antiretroviral Drug Selection.
J Int Assoc Provid AIDS Care
; 14(5): 398-401, 2015.
Article
in En
| MEDLINE
| ID: mdl-26188010
ABSTRACT
Transmitted HIV-1 exhibiting reduced susceptibility to protease and reverse transcriptase inhibitors is well documented but limited for integrase inhibitors and enfuvirtide. We describe here a case of transmitted 5 drug class-resistance in an antiretroviral (ARV)-naïve patient who was successfully treated based on the optimized selection of an active ARV drug regimen. The value of baseline resistance testing to determine an optimal ARV treatment regimen is highlighted in this case report.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
HIV Infections
/
HIV-1
/
Anti-Retroviral Agents
Limits:
Adult
/
Humans
/
Male
Language:
En
Journal:
J Int Assoc Provid AIDS Care
Year:
2015
Document type:
Article
Affiliation country:
Estados Unidos